Evidence map›Paper›PMID 32627205›Full record

Trial reportTransfusion2020

Blood donor recruitment in Guangzhou, China, during the 2019 novel coronavirus (COVID-19) epidemic.

Jian Ou-Yang, Shi-Jie Li, Chun-Hua Bei, Bo He, Jin-Yan Chen, Hua-Qin Liang, Yong-Shui Fu

Open access · bronzeAbstract readObservational StudyRandomized Controlled Trial
In one paragraph

Trial report in Transfusion, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Motivations and deterrents of blood donation among blood donors during the COVID-19 pandemic in Hong Kong.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  10. Article
  11. The Impact of COVID-19 on Blood Transfusion Services: A Systematic Review and Meta-Analysis.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2021
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jian Ou-YangGuangzhou Blood Center, Guangzhou, Guangdong, China.ORCID 0000-0002-6746-8906
Shi-Jie LiGuangzhou Blood Center, Guangzhou, Guangdong, China.
Chun-Hua BeiGuangzhou Blood Center, Guangzhou, Guangdong, China.
Bo HeGuangzhou Blood Center, Guangzhou, Guangdong, China.
Jin-Yan ChenGuangzhou Blood Center, Guangzhou, Guangdong, China.ORCID 0000-0003-4103-7056
Hua-Qin LiangGuangzhou Blood Center, Guangzhou, Guangdong, China.
Yong-Shui FuGuangzhou Blood Center, Guangzhou, Guangdong, China.
Guangzhou Blood Center · CN

Funding

Medical Science and Technology Research Foundation of Guangdong Province 2020 B2020141Natural Science Foundation of Guangdong Province 2019 2019A1515011505The Key Medical Disciplines and Specialties Program of Guangzhou
6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) epidemic affected blood collection in Guangzhou, China. STUDY DESIGN AND

methodsThis paper includes three studies. The observational study reported the trends of blood collection during the epidemic in Guangzhou, China. The cross-sectional survey investigated factors influencing blood donation during the COVID-19 epidemic, and a self-administered questionnaire was given to 1584 street whole blood donors (SWBDs) who donated during the epidemic. The randomized controlled trial involved 19 491 SWBDs who donated in 2019 but did not donate during the epidemic. Trial participants were randomly assigned to two intervention groups: Group 1 completed Questionnaire 1, which contained precautionary measures in response to COVID-19 and other messages about blood donation during the epidemic; Group 2 completed Questionnaire 2, which did not include this information. A control group did not receive any questionnaire.

resultsAs measures were implemented, the number of blood donors increased accordingly. Both first-time and repeat SWBDs perceived the same level of blood need and donated blood because it would save lives. SWBDs who completed Questionnaire 1 expressed a greater intention to donate during the epidemic. Enabling blood donors to perceive a higher level of blood need and a lower level of COVID-19 infection risk related to blood donation mobilized experienced SWBDs to donate within 3 weeks. Intention-to-treat analyses and average-treatment-effect-on-the-treated estimations confirmed that Questionnaire 1 could motivate SWBDs to actually donate blood.

conclusionVarious measures could ease blood shortage during the COVID-19 epidemic. Administration of Questionnaire 1 could increase blood donations during the epidemic.

Indexed as

Patient SelectionAdultBlood DonorsChinaCOVID-19Cross-Sectional StudiesFemaleHumansMaleMiddle AgedPandemicsSARS-CoV-2Surveys and QuestionnairesYoung Adult

Identifiers

PMID32627205
PMCPMC7361411
OpenAlexW3039882056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.